Invivyd aligns with FDA on fast-track approval path for COVID-19 antibody VYD2311

1 hour ago 1

Invivyd (NASDAQ:IVVD) received guidance from the U.S. Food and Drug Administration and is aligned with a streamlined, expedited pathway toward potential biologics license application approval for its novel monoclonal antibody candidate, VYD2311, aimed at preventing COVID-19.

BLA pathway for VYD2311

Recommended For You

More Trending News

Read Entire Article
  1. Homepage
  2. Finance
  3. Invivyd aligns with FDA on fast-track approval path for COVID-19 antibody VYD2311

Related

Sigma Lithium GAAP EPS of -$0.17, revenue of $16.89M

Sigma Lithium GAAP EPS of -$0.17, revenue of $16.89M

16 minutes ago 0
‘Seekho Paiso ki Bhasha’: How to build regular cash flow using a systematic withdrawal plan? Market veteran Nilesh Shah weighs in

‘Seekho Paiso ki Bhasha’: How to build regular cash flow usi...

22 minutes ago 0
Digi Power X GAAP EPS of -$0.34

Digi Power X GAAP EPS of -$0.34

27 minutes ago 0
Unitil prices public offering of 1.39M shares at $46.65 each, stock drops

Unitil prices public offering of 1.39M shares at $46.65 each...

33 minutes ago 0
XPeng and Volkswagen accelerate E/E architecture development

XPeng and Volkswagen accelerate E/E architecture development...

40 minutes ago 0
Circle prices 10M share public offering at $130 each

Circle prices 10M share public offering at $130 each

47 minutes ago 0
Trump, Putin Alaska Meet: Stakes high as Ukraine war, European security hang in balance

Trump, Putin Alaska Meet: Stakes high as Ukraine war, Europe...

52 minutes ago 0
Drive Shack GAAP EPS of -$0.05, revenue of $93.17M

Drive Shack GAAP EPS of -$0.05, revenue of $93.17M

54 minutes ago 0
Origin Materials files $100M mixed securities shelf

Origin Materials files $100M mixed securities shelf

57 minutes ago 0
Gambling.com files to sell 6.7M shares of common stock for holders

Gambling.com files to sell 6.7M shares of common stock for h...

58 minutes ago 0
Qifu Technology boosts semi-annual dividend by 8.6% $0.76/ADS

Qifu Technology boosts semi-annual dividend by 8.6% $0.76/AD...

1 hour ago 0
Accenture boosts Asia-Pacific cybersecurity with acquisition of CyberCX

Accenture boosts Asia-Pacific cybersecurity with acquisition...

1 hour ago 0
Twilio set to join S&P MidCap 400

Twilio set to join S&P MidCap 400

1 hour ago 1
79th Independence Day: PM Modi unveils vision for next-generation GST reforms to boost relief, simplification and economic growth

79th Independence Day: PM Modi unveils vision for next-gener...

1 hour ago 1
China's economy slows as industrial production, retail sales both miss targets; Jobless rate climbs to 5.2% in July

China's economy slows as industrial production, retail sales...

2 hours ago 0
Goldman is said to offer investors stakes in Millennium for just $1 million

Goldman is said to offer investors stakes in Millennium for ...

2 hours ago 0
HIVE Digital Technologies reports Q1 results

HIVE Digital Technologies reports Q1 results

2 hours ago 1
Mahindra launches NU IQ global platform to target premium SUV market

Mahindra launches NU IQ global platform to target premium SU...

2 hours ago 1
Asia markets mixed; Japan rises on strong GDP, Hong Kong falls on weak China data

Asia markets mixed; Japan rises on strong GDP, Hong Kong fal...

2 hours ago 1
Cibus targets $200M annual royalty revenue from rice traits as regulatory landscape evolves

Cibus targets $200M annual royalty revenue from rice traits ...

2 hours ago 1

Trending

1. acl 2
2. afc champions league 2
3. mobland
4. samsung s24
5. shoaib akhtar
6. junior movie ott release date
7. mission impossible
8. shashi tharoor
9. lakshya sen
10. superman james gunn

Popular

عکس پربازدید از فرزند تازه متولد شده پیمان‌قاسم‌خانی

عکس پربازدید از فرزند تازه متولد شده پیمان‌قاسم‌خانی

3 days ago 5
عکس | ماه کامل بر فراز حرم امام حسین (ع)

عکس | ماه کامل بر فراز حرم امام حسین (ع)

5 days ago 5
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved